Answers are grounded in this paper and cite their sources.
Integrated bioinformatics analysis identifies novel diagnostic biomarkers and therapeutic targets in chronic kidney disease progression, suggesting a crucial role for the NEAT1/miR-124-3p/CCL2 axis.
Background Chronickidney disease (CKD) is a major global health burden lacking effectivetherapies. Renal interstitial fibrosis (RIF) is a key pathological driver ofCKD progression. This study aimed to identify novel diagnostic biomarkers and therapeutictargets.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: